Megan E Speer1, Monica L Huang1, Basak E Dogan2, Beatriz E Adrada1, Rosalind P Candelaria1, Kenneth R Hess3, Palita Hansakul4, Wei T Yang1, Gaiane M Rauch1. 1. 1 Department of Diagnostic Radiology, Section of Breast Imaging, The University of Texas MD Anderson Cancer Center , Houston, TX , USA. 2. 2 Department of Diagnostic Radiology, Division of Breast Imaging, The University of Texas Southwestern Medical Center , Dallas, TX , USA. 3. 3 Department of Biostatistics, Division of Science, The University of Texas MD Anderson Cancer Center , Houston, TX , USA. 4. 4 Department of Diagnostic Radiology, Division of Breast Imaging, King Chulalongkorn Memorial Hospital , Bangkok , Thailand.
Abstract
OBJECTIVE: : To determine whether breast MRI-guided vacuum-assisted biopsy (MRI-VAB) high-risk lesion histology influences surgical or long-term imaging follow-up outcomes. METHODS: : Patients with imaging-concordant high-risk findings on 9-gauge breast MRI-VAB between January 2007 and July 2012 who had surgical histopathology or 2 year imaging follow-up were retrospectively reviewed. RESULTS: : 90 patients with 99 lesions were included. Lesions were atypical ductal hyperplasia (ADH) (n = 21), lobular neoplasia [n = 36; atypical lobular hyperplasia (ALH) (n = 22), lobular carcinoma in situ (LCIS) (n = 6), and ALH plus LCIS (n = 8)], and other high-risk lesion (n = 42; papillary lesions, radial scar, flat epithelial atypia, atypia unspecified). Of 53 excised lesions, 6 (11%) were upgraded to invasive cancer or ductal carcinoma in situ (DCIS). 4 of 21 (19%) ADH lesions were upgraded to DCIS. 2 of 36 (6%) lobular neoplasia lesions, both combined ALH and LCIS, were upgraded to DCIS, and invasive lobular carcinoma, respectively. The remaining 46 lesions were managed conservatively with imaging follow-up: 17 (37%) had mammography only, while 29 (63%) had mammography and MRI follow-up. There was no evidence of breast cancer development at the site of MRI-VAB in the cases with only imaging follow-up. CONCLUSION: : We conclude that the upgrade rate for high-risk lesions at MRI-VAB at surgical excision is low. Surgical excision is warranted for ADH and combined ALH-LCIS lesions. For other lesions, a multidisciplinary approach to decide on personalized management may be appropriate. ADVANCES IN KNOWLEDGE:: Surgical excision is warranted for ADH lesions and combined ALH-LCIS lesions identified at breast MRI-VAB. A multidisciplinary approach to patient management of other high-risk lesions may be appropriate.
OBJECTIVE: : To determine whether breast MRI-guided vacuum-assisted biopsy (MRI-VAB) high-risk lesion histology influences surgical or long-term imaging follow-up outcomes. METHODS: : Patients with imaging-concordant high-risk findings on 9-gauge breast MRI-VAB between January 2007 and July 2012 who had surgical histopathology or 2 year imaging follow-up were retrospectively reviewed. RESULTS: : 90 patients with 99 lesions were included. Lesions were atypical ductal hyperplasia (ADH) (n = 21), lobular neoplasia [n = 36; atypical lobular hyperplasia (ALH) (n = 22), lobular carcinoma in situ (LCIS) (n = 6), and ALH plus LCIS (n = 8)], and other high-risk lesion (n = 42; papillary lesions, radial scar, flat epithelial atypia, atypia unspecified). Of 53 excised lesions, 6 (11%) were upgraded to invasive cancer or ductal carcinoma in situ (DCIS). 4 of 21 (19%) ADH lesions were upgraded to DCIS. 2 of 36 (6%) lobular neoplasia lesions, both combined ALH and LCIS, were upgraded to DCIS, and invasive lobular carcinoma, respectively. The remaining 46 lesions were managed conservatively with imaging follow-up: 17 (37%) had mammography only, while 29 (63%) had mammography and MRI follow-up. There was no evidence of breast cancer development at the site of MRI-VAB in the cases with only imaging follow-up. CONCLUSION: : We conclude that the upgrade rate for high-risk lesions at MRI-VAB at surgical excision is low. Surgical excision is warranted for ADH and combined ALH-LCIS lesions. For other lesions, a multidisciplinary approach to decide on personalized management may be appropriate. ADVANCES IN KNOWLEDGE:: Surgical excision is warranted for ADH lesions and combined ALH-LCIS lesions identified at breast MRI-VAB. A multidisciplinary approach to patient management of other high-risk lesions may be appropriate.
Authors: Jennifer R Kohr; Peter R Eby; Kimberly H Allison; Wendy B DeMartini; Robert L Gutierrez; Sue Peacock; Constance D Lehman Journal: Radiology Date: 2010-02-19 Impact factor: 11.105
Authors: Claudia Perlet; Sylvia H Heywang-Kobrunner; Anke Heinig; Harald Sittek; Jan Casselman; Ingvar Anderson; Patrick Taourel Journal: Cancer Date: 2006-03-01 Impact factor: 6.860
Authors: Laura Liberman; Nanette Bracero; Elizabeth Morris; Cynthia Thornton; D David Dershaw Journal: AJR Am J Roentgenol Date: 2005-07 Impact factor: 3.959
Authors: Laura Liberman; Agnes E Holland; Domagoj Marjan; Melissa P Murray; Lia Bartella; Elizabeth A Morris; D David Dershaw; Ralph T Wynn Journal: AJR Am J Roentgenol Date: 2007-03 Impact factor: 3.959
Authors: Eumee Cha; Emily B Ambinder; Eniola T Oluyemi; Lisa A Mullen; Babita Panigrahi; Joanna Rossi; Philip A Di Carlo; Kelly S Myers Journal: Breast Cancer Res Treat Date: 2022-10-15 Impact factor: 4.624
Authors: Jacky D Luiten; Bram Korte; Adri C Voogd; Willem Vreuls; Ernest J T Luiten; Luc J Strobbe; Matthieu J C M Rutten; Menno L Plaisier; Paul N Lohle; Marianne J H Hooijen; Vivianne C G Tjan-Heijnen; Lucien E M Duijm Journal: Int J Cancer Date: 2019-05-02 Impact factor: 7.396